Search Results 601-610 of 18464 for Prednisone

1. A Study In Adults With Moderate To Severe Dermatomyositis - Mayo Clinic

   Investigator site staff or members of their family. · Acute and Chronic present medical conditions. · Intake of greater than 15 mg of prednisone or equivalent per ...

2. A Study to Evaluate PDS0101 and Pembrolizumab Combination to Treat Subjects with HPV16 + Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   disease (GVHD). - Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) ...

3. A Study to Evaluate the Effectiveness and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects with Mycosis Fungoides - Mayo Clinic

   More than 3 short courses (≤ 7 days) of prednisone equivalent > 10 mg per day within 8 weeks prior to Screening; however, a stable regimen of systemic ...

4. A Study To Compare Standard Therapy To Treat Hodgkin Lymphoma To The Use Of Two Drugs, Brentuximab Vedotin And Nivolumab - Mayo Clinic

   ... prednisone for patients >= 18 years or > 0.5 mg/kg [up to 10 mg/day] for ... prednisone equivalents) are permitted in the absence of active autoimmune disease.

5. A Study to Compare Venetoclax with Fulvestrant vs. Fulvestrant Alone in Women with Locally Advanced or Metastatic HER2-negative Cancer who Have Progressed or Recurred on a CDK4/6 Inhibitor - Mayo Clinic

   Recovered from significant (Grade ≥ 3) acute toxicity with no ongoing requirement for ≥10 mg of prednisone per day or an equivalent dose of other ...

6. A Study to Evaluate the Immune Response to Anti-HER2 Therapies - Mayo Clinic

   NOTE: Inhaled steroids, low-dose corticosteroids (e.g., equivalent to or less than oral prednisone 10 mg daily), and steroid use for primary prevention of ...

7. A Study of Adjunctive Ganaxolone Treatment in Children and Young Adults with CDKL5 Deficiency Disorder - Mayo Clinic

   Patients on ACTH, prednisone or other systemically (non-inhaled) administered steroids should be off the product greater than 28 days prior to screening.

8. ADG126 In Combination With Pembrolizumab In Patients With Advanced/Metastatic Solid Tumors - Mayo Clinic

   Patients requiring systemic treatment with corticosteroids or other immunosuppressive medications (\>10 mg/day prednisone or equivalent). 9. Any ...

9. Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma - Mayo Clinic

   Condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalent) or other immunosuppressive medications within 14 days ...

10. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Participation eligibility · Receiving corticosteroids > 10 mg of prednisone per day (or equivalent); · Known positivity for human immunodeficiency virus (HIV);.